Cantabio Pharmaceuticals Competitors and Similar CompaniesClear all
Cantabio Pharmaceuticals's competitors and similar companies include Hutchison China Meditech.
 Cantabio Pharmaceuticals Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | |
Founding Date | Founding Date 2009 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Palo Alto, US HQ Budapest, HU | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more |
Employees | Employees 11 | Employees 1,811 |
Valuation ($) | Valuation ($) 563.6 k | Valuation ($) 3.6 b |
Financial | ||
Net income | Net income ($2m) (FY, 2018) | Net income $435.1m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Hutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company